BHVNBiohaven Ltd.

$16.95

Who owns BHVN

272 institutions reported holding BHVN for 2026Q1, together 98% of the company, more than the 271 a quarter earlier.

272

Institutions reporting a position · as of 2026Q1 · up from 271 the quarter before

Shares held by institutions
144.2M

Shares held by institutions · 98% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.22B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
38%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
36
New positions
37
Positions exited
41
Added to
115
Reduced
59
Top 10 holdersof the company
52%
Institutional ownership by quarter, 2017Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1272144.2M$1.22B
2025Q4271123.8M$1.40B
2025Q326485.2M$1.28B
2025Q225087.8M$1.24B
2025Q126491.3M$2.24B
2024Q425793.1M$3.51B
2024Q325486.9M$4.34B
2024Q222883.5M$2.90B
2024Q124174.9M$4.10B
2023Q421972.3M$3.09B
2023Q318762.0M$1.61B
2023Q218660.8M$1.45B
2023Q117667.1M$921M
2022Q418063.0M$882M
2022Q327267.1M$9.24B
2022Q232061.0M$8.88B
Largest reported holders, 2026Q1
HolderShares% of companyValue
HENDERSON GROUP PLC17.5M12%$148M
BlackRock Inc.11.2M7.6%$95M
SUVRETTA CAPITAL MANAGEMENT, LLC10.3M7.0%$87M
BARCLAYS PLC10.1M6.8%$85M
STATE STREET CORP6.6M4.5%$56M
INFINITUM ASSET MANAGEMENT, LLC6.3M4.2%$53M
TCG Crossover Management, LLC4.6M3.1%$39M
VANGUARD GROUP INC4.4M3.0%$37M
Royalty Pharma Sub-Manager, LLC2.9M2.0%$25M
D. E. Shaw & Co., INC.2.8M1.9%$24M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…